Match each patient's clinical profile with the most appropriate contraceptive method based on the Medical Eligibility Criteria for Contraceptive Use.
- A 34-year-old woman with active breast cancer who desires a highly effective, long-acting reversible contraceptive method.Copper intrauterine device
- A 26-year-old woman with Wilson disease and a bicornuate uterus who desires a highly effective, long-acting reversible contraceptive method.Subdermal etonogestrel implant
- A 29-year-old woman with a history of unprovoked deep vein thrombosis and heavy menstrual bleeding causing symptomatic anemia.Levonorgestrel-releasing intrauterine device
- A 23-year-old woman with sickle cell disease who desires a highly effective contraceptive method that may also decrease the frequency of her vaso-occlusive pain crises.Depot medroxyprogesterone acetate
Answer
The correct matches depend on identifying absolute contraindications and secondary benefits. Active breast cancer requires the hormone-free copper intrauterine device. Wilson disease and a bicornuate uterus necessitate the subdermal etonogestrel implant to avoid copper toxicity and uterine placement. Deep vein thrombosis with heavy bleeding is best managed with the levonorgestrel-releasing intrauterine device. Sickle cell disease benefits uniquely from depot medroxyprogesterone acetate.
Each correct pairing navigates the Medical Eligibility Criteria by avoiding Category 4 conditions (e.g., placing hormones in breast cancer patients, placing any device in a distorted uterine cavity) while maximizing secondary benefits (e.g., treating heavy bleeding with a levonorgestrel device, preventing pain crises with depot injections).
Step-by-Step Solution
Key Concept
Applying the Medical Eligibility Criteria for contraceptive use to navigate complex absolute contraindications (Category 4) and utilize non-contraceptive benefits.
Estimated Time:1m 30s